Ibere Pharmaceuticals
NYSE: IBER0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Osagie O. Imasogie
- Headquarters
- Philadelphia, United States
- Market cap
- $175.6M
- Website
- https://www.iberepharma.com
Loading IBER…
Loading profile data…Frequently asked questions about IBER
What does Ibere Pharmaceuticals (IBER) do?
Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Where does IBER trade?
Ibere Pharmaceuticals (IBER) trades on the New York Stock Exchange.
What sector is IBER in?
Ibere Pharmaceuticals (IBER) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Ibere Pharmaceuticals?
Osagie O. Imasogie is the chief executive officer of Ibere Pharmaceuticals (IBER).
Where is Ibere Pharmaceuticals headquartered?
Ibere Pharmaceuticals is headquartered in United States.
Does IBER pay a dividend?
Ibere Pharmaceuticals (IBER) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.